PE-22-28vs Selank Peptide PE-22-28 is a subject of significant interest in neuroscience research, primarily recognized for its potent inhibitory action on the TREK-1 potassium channel. This peptide, a synthetic derivative of the naturally occurring molecule Spadin, is composed of seven amino acids and exhibits an impressive IC50 value of 0.PE-22-28is apeptidetherapy designed to support mood regulation, cognitive function, and depression management. Derived from Spadin, a naturally occurring ...12 nM for TREK-1 inhibitionThe products are not medicines or drugs and they have not been approved by the fda to prevent, treat, diagnose, mitigate, or cure any disease, ailment or .... Emerging research suggests that PE-22-28 possesses considerable potential in mitigating depression and supporting neurogenesis, offering a promising avenue for further investigation into mood regulation and cognitive function.
The core mechanism of action for PE-22-28 lies in its ability to block the TREK-1 (TWIK-related KCNK2) channel. TREK-1 is a background potassium channel that plays a crucial role in neuronal excitability and is implicated in various neurological processes, including pain perception and mood regulationPE 22-28 | CAS NO.:1801959-12-5. By inhibiting TREK-1, PE-22-28 can modulate neuronal firing patterns. Studies have demonstrated that PE-22-28 can reduce apoptotic death in rodent models of ischemia, suggesting a neuroprotective effect. Its efficacy as a TREK-1 inhibitor has made it a foundational sequence for the design of various analogs with potentially enhanced stability and efficacyPE 22-28, a TREK-1 inhibitor exhibiting an IC50 value of 0.12 nM,is a 7 amino-acid peptide. It serves as a foundational sequence for the creation of analogs ....
A significant area of focus for PE-22-28 research is its potential as an antidepressant.2021年7月22日—PE-22-28 appears to be the newest peptide for fixing major depressive disorder, at least according to world-renowned peptide physician Dr. Elizabeth Yurth. Preliminary findings indicate that PE-22-28 may help manage depression, with some studies suggesting a rapid onset of action compared to traditional antidepressant medications.PE-22-28 has shown potential in reducing neuroinflammation and oxidative stress, factors that are often linked to cognitive decline and neurological conditions. Furthermore, research has shown that PE-22-28 can increase neurogenesis, the process by which new neurons are formed, and upregulate levels of postsynaptic density protein 95 (Psd-95), a marker for increased synaptogenesis. These effects are crucial for overall brain health and function, and their enhancement by PE-22-28 could contribute to its mood-lifting and cognitive-supportive properties. The peptide's potential to mitigate depression has been highlighted, with investigations exploring its rapid impact without adversely affecting other functions governed by the TREK-1 channel.作者：A Djillani·2017·被引用次数：38—In vivo, the antidepressant properties ofPE 22-28and its derivatives were demonstrated in behavioral models of depression, such as the forced ...
The structure of PE-22-28, being a relatively short peptide, lends itself well to chemical modifications and amino acid substitutionsPE 22-28 is a TREK-1 inhibitor with IC 50 value of 0.12 nM. PE 22-28 also is a 7 amino-acid peptide that is used as a core sequence for preparing analogs.. This has led to the development of several analogs derived from PE-22-28, aiming to improve its therapeutic profile. Researchers are exploring these shortened Spadin analogs for their enhanced stability and efficacy in blocking the TREK-1 channel. The specificity of PE-22-28 has also been a subject of study, with comparisons made against other potassium channels like TREK-2, TRAAK, and TRESK to understand its precise interactions.Novel lacto-peptides improve cognitive decline - PMC - NIH
While PE-22-28 shows promising potential, it is important to note that it is primarily a research peptideWhat is BPC 157 - The Peptide Huberman and Rogan Can't Stop .... Products containing PE-22-28 are typically intended for laboratory use and are not approved by regulatory bodies like the FDA for treating, diagnosing, mitigating, or curing any disease or ailmentPE 22-28. Purity levels, such as >98% or >99% as indicated by HPLC testing, are crucial for reliable research outcomes. Storage conditions, including lyophilized form at -20°C or reconstituted form at 2-8°C, are also important for maintaining peptide integrity. Dosage protocols and potential side effects are areas that continue to be explored in ongoing researchShortened Spadin Analogs Display Better TREK-1 Inhibition ....
In conclusion, peptide PE-22-28 stands out as a potent TREK-1 inhibitor with significant demonstrated potential in preclinical studies for depression management and the promotion of neurogenesis.Fighting against depression with TREK-1 blockers Its synthetic nature, derived from Spadin, and its efficacy in blocking TREK-1 channels position it as a valuable tool in neuroscience research, paving the way for the development of novel therapeutic strategies for mood disorders and cognitive declinePE-22-28 For Sale (8mg).
Join the newsletter to receive news, updates, new products and freebies in your inbox.